CymitQuimica logo

Navicixizumab

CAS:

Ref. TM-T76871

1mg
To inquire
2mg
To inquire
10mg
To inquire
5mg
1,144.00€
Navicixizumab
Targetmol

Product Information

Name:Navicixizumab
Brand:Targetmol
Description:Navicixizumab, a bispecific VEGF/DLL4 inhibitor, pairs with Paclitaxel in ovarian and other cancer research.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Color/Form:Liquid

Technical inquiry about: Navicixizumab

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please add the desired products to your cart and manage the request from there. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.